Delivering Advanced Healthcare Solutions Through Research And Innovation To Improve The Quality Of Human Life

In The News

Initial experience with the new ethylene vinyl alcohol copolymer based liquid embolic agent Menox in the endovascular treatment of cerebral arteriovenous malformations

December 25, 2019

Initial experience with the new ethylene vinyl alcohol copolymer based liquid embolic agent Menox in the endovascular treatment of cerebral arteriovenous malformations

Background and Purpose Liquid embolic agents (LEAs) are the determinant tool for successful embolization of cranial arteriovenous shunts. There are few currently available LEAs.

In The News

MeRes100 BRS, the first bioresorbable vascular matrix to treat coronary artery disease

December 25, 2019

MeRes100 BRS, the first bioresorbable vascular matrix to treat coronary artery disease

MeRes100 BRS - the first thin-tip sirolimus releasing bioresorbable vascular matrix - shows positive long-term safety consistent with low cardiac event rates and zero matrix stent thrombosis for patients with coronary artery disease   

Our People

“Every individual has within their abilities the capability of accomplishing extraordinary things. They just have to learn how to do it.” - Brian Tracy

November 26, 2019

“Every individual has within their abilities the capability of accomplishing extraordinary things. They just have to learn how to do it.”  - Brian Tracy

Meril Academy always showcase zeal to conduct more educational program and invite healthcare professional of different genre to heave a platform for learning and proliferating skills. 

ABOUT

Founded in 2006, Meril is an India-based global medical device company that is dedicated to the innovation, design and development of novel, clinically relevant and state-of-the-art devices


LEARN MORE
Enquire
Now